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Topic 10 – Pediatric and congenital heart
disease
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Infective endocarditis in patients with ventricular septal defect
Magali Veyrier, Alexandra Soufi, Mohamed Bakloul, Jean Ninet, Olivier
Metton, François Sassolas, André Bozio, Sylvie Di Filippo
Hôpital Cardiovasculaire, Cardiologie pédiatrique et congénitale, Lyon,
France
In the context of recent change in guidelines for prophylaxis of infective
endocarditis (IE), the objective of this study was to assess the features and
outcomes of IE in children and adults with non-significant ventricular septal
defect (VSD).
Methods: A retrospective analysis of records of patients with non-signifi-
cant VSD. Clinical, echocardiographic and microbiological data, and outcos
were assessed.
Results: From 1980 to 2013, 57 IE occurred (1 to 4 per year), in patients
aged 14.2±11.3y (med12.1), 29males (51%) and 39 were <18y of age. VSD
was membranous in all cases, isolated (39=68.5%) or associated with mild
aortic regurgitation or pulmonary stenosis. VSD was native in 39 (68.5%) and
not diagnosed before IE occurred in 4cases (7%). The cause of infection was
unknown in 36% of the cases, while 23% were from dental, 13% from cuta-
neous, 9% from ENT or digestive origin, and 19% occurred in the early post-
operative course of patch closure, i.e. 81% of the cases occurred in native mild
VSD. Streptococcus from dental origin was the most frequent causal agent
(54.5%), staphylococcus was found in 35% of cases, Gram-negative bacillus
in 3.5%. Hemocultures were negative in 7% of the cases. Vegetation was the
most frequent echographic lesion, and located either on VSD, and/or tricuspid
valve and/or RV free wall and/or pulmonary valve. Aortic valve location
occurred in 8cases. Embolic event occurred in 28cases (49%): multiple pulmo-
nary embolia in 21 (37%), systemic embolia in 6. Eighteen patients were oper-
ated (31.6%): early surgery in 11 (19.3%), delayed patch closure in 7. Six
patients died (10.5%). Death was not related to early surgery. FU was
13.4±11.2y (med 10.2y). 
Conclusion: Infective endocarditis impairs prognosis of mild membranous
VSD and dental events are the most frequent origin of infection. Preventive
surveillance and management of any dental lesion are probably to be empha-
sized in these patients. 
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Outcomes of pediatric hypertrophic cardiomyopathy associated with
RASopathy
Olivier Guillard, Diala Khraiche, Francesca Raimondi, Fanny Bajolle,
Pascal Vouhé, Damien Bonnet
CHU Hôpital Necker Enfants Malades-APHP, M3C, Cardiologie congéni-
tale et pédiatrique, Paris, France
Background: The outcomes of pediatric hypertrophic cardiomyopathy
(HCM) associated to RASopathies are scarcely known. 
Aim: To describe outcomes of pediatric HCM associated with RASopathy. 
Methods and results: 80 cases of children with a clinical phenotype of
RASopathy and HCM were included. Age at diagnosis of HCM was 11.7
months (range 0 to 168). The HCM was diagnosed prenatally in 9 cases, and
before one year of age in 58 cases. 67 had Noonan syndrome, 9 had Cardio-
facio-cutaneous syndrome, 3 had Costello syndrome, and 1 had Noonan syn-
drome with multiples lentigines. The HCM was obstructive in 37 cases. Asso-
ciated cardiac defects were right ventricular outflow tract obstruction in
40 children, polyvalvular dysplasia in 18, atrial septal defect (ASD) in 13,
ventricular septal defect in 3, congenital mitral regurgitation in 2, persistent
arterial duct in 2, left superior caval vein in 2, aortic arch anomaly in 2, cor-
onary anomaly in 1, and systemic arteriovenous fistula in 1. Nineteen children
underwent a Konno operation for obstructive HCM. Additional surgical pro-
cedures were 9 right ventricular outflow tract surgical reliefs, 9 percutaneous
dilatations of pulmonary valve stenosis, 4 percutaneous closures of ASD, 1 tri-
cuspid valve repair, 1 Brom procedure with aortic valve repair, 1 aortic valve
replacement, and 1 coronary artery bypass. Overall mortality was 21%. Four-
teen (82%) deaths occurred before 1 year of life. Causes of death were cardiac
in 10 cases including two sudden deaths, related to respiratory diseases causes
in 5, and in utero fœtal death in 1. Factors predicting mortality were diagnosis
before 2 months of life (HR=4,33, p<0,001), fœtal diagnosis of HCM
(HR=3,64, p<0,001), and surgery before one year of life (HR=3,43, p=0,001). 
Conclusion: Mortality of children with HCM due to RASopathy is high
and occurs early in life. Main risk factors are early diagnosis of HCM
including prenatal diagnosis, and need for surgery before one year of life. 
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3D transthoracic echocardiography to assess ventricular septal defect
anatomy and severity
Khaled Hadeed (1), Sébastien Hascoët (2), Yves Dulac (1), Romain Ama-
dieu (1), Philippe Acar (1)
(1) CHU Toulouse, Hôpital des enfants, Pediatric cardiology, Toulouse,
France – (2) CHU Toulouse, Hôpital des enfants, Pediatric cardiac sur-
gery, Toulouse, France
The pathophysiology of Ventricular Septal Defect (VSD) is determined by
the size of the defect and the state of the pulmonary vascular resistance. We
assessed the morphology of VSD using 3D transthoracic echocardiography
(3D-TTE) and the ability to estimate the pathophysiology.
Methods: We prospectively enrolled 48 children with isolated unique mus-
cular (77%) and membranous VSD (23%). Severity of the VSD was rated
according to their pathophysiology. (Type 1: minor left-to-right shunt; 2a: sig-
nificant left-to-right shunt (left ventricular end diastolic diameter (LVEDD) Z-
score >2); 2b: VSD associated with pulmonary hypertension). VSD measure-
ments were obtained after a multi-planar reconstruction of a TTE 3D full
volume (X5-1 or X7-2 matrix probes, ie33, Philips). Diagnosis properties of
the ratio of 3D-VSD area to aortic annulus area (3DA/AAA), 3D-VSD area to
body surface area (3DA/BSA) and 2Dmax diameter to BSA (2DD/BSA) were
compared.
Results: Median age was 8.5 month-old (min 1 max 123). LVEDD Zscore
was>2 in 19 children (40%), of whom 12 (25%) had pulmonary hypertension.
3D-VSD systolic area, 3D and 2D maximal diameters were correlated with
LVEDD. (r=0.71, r=0.52, r=0.55, p<0.05). Systolo-diastolic variation of 3D
VSD area was higher in muscular than in membranous VSD (Median
54%vs27%, p=0.0001). VSD were asymmetric with a mean ratio of maximal
to minimal 3D diameters of 2.1±1.3 in membranous VSD and 3.2±1.5 in mus-
cular VSD (p=0.01). VSD severity was correlated with 3DA/AAA and 3DA/
BSA ratio (r=0.63, r=0.60, p<0.05), but not with the 2DD/BSA ratio. Ability
to diagnose type 2b VSD was higher with the 3DA/AAA or 3DA/BSA ratio
than the 2D/BSA ratio (ROC area 0.97 and 0.96 vs 0.85). A 3DA/AAA
ratio>0.39 has a sensitivity of 92% and a specificity of 97% to diagnose a 2b-
VSD. 
Conclusion: 3D-TTE allows a morphological and a quantitative assess-
ment of muscular and membranous VSD. The 3DA/AAA ratio is an accurate
diagnostic tool to assess the pathophysiology of the VSD (figure next page). 
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Conservative surgery for congenital mitral valve stenosis: is it best
option?
Marianne Peyre, Lucile Houyel, Emre Belli
Centre Chirurgical Marie Lannelongue, Plessis Robinson, France
Objectives: Congenital mitral valve stenosis (CMVS) is a heterogeneous
group of lesions that can be isolated or part of left heart obstructive syndrom.
Historically, mitral valve surgery has been associated with significant mor-
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